Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A man with skin and hair symptoms improved partially with specific treatment.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

Using special RNA to target a mutant gene fixed hair problems in mice.

New delivery systems are improving siRNA treatments for skin conditions.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Mitotane changes steroid breakdown, affecting cortisol availability.